Trial Profile
Subanalyses of non‐motor symptoms and clinical global impression in Spanish advanced Parkinson's disease patients treated with levodopa‐carbidopa intestinal gel: E-DUO Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Aug 2015
Price :
$35
*
At a glance
- Drugs Levodopa/carbidopa (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- 28 Aug 2015 New trial record
- 18 Jun 2015 Results of subgroup analysis assessing discontinuation factors presented at the 19th International Congress of Parkinson's Disease and Movement Disorders.
- 18 Jun 2015 Results presented at the 19th International Congress of Parkinson's Disease and Movement Disorders.